biote Corp (BTMD)

Currency in USD
2.28
+0.14(+6.32%)
Real-time Data·
BTMD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.152.31
52 wk Range
2.035.15
Key Statistics
Prev. Close
2.14
Open
2.15
Day's Range
2.15-2.31
52 wk Range
2.03-5.15
Volume
90.68K
Average Volume (3m)
150.08K
1-Year Change
-55.0296%
Book Value / Share
-2.3
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BTMD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
4.21
Upside
+84.74%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

biote Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

biote Corp Company Profile

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.

biote Corp Earnings Call Summary for Q3/2025

  • Biote Corp reported Q3 2025 EPS of $0.22, beating forecasts by 69.23%, while revenue missed at $48 million (8.62% below expectations), driving a 2.45% stock increase.
  • Despite a 6.7% YoY revenue decline, dietary supplements grew 8.4% to $11.2 million, and gross profit margin improved by 150 basis points to 71.8%.
  • The company maintained its 2025 guidance with revenue above $190 million and adjusted EBITDA exceeding $50 million, projecting mid-teens growth in dietary supplements.
  • Management highlighted 'disciplined execution' while acknowledging challenges including 8% provider attrition rates and increased competition in hormone optimization therapy.
Last Updated: 05/11/2025, 23:12
Read Full Transcript

Compare BTMD to Peers and Sector

Metrics to compare
BTMD
Peers
Sector
Relationship
P/E Ratio
3.6x−2.4x−0.6x
PEG Ratio
0.010.100.00
Price/Book
−1.4x1.4x2.6x
Price / LTM Sales
0.5x4.3x3.3x
Upside (Analyst Target)
99.1%56.6%45.0%
Fair Value Upside
Unlock3.7%6.5%Unlock

Analyst Ratings

4 Buy
1 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 4.21
(+84.74% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
B.Riley
Hold3.00+32.16%4.00Maintain06/11/2025
Jefferies
Buy5.56+144.93%5.92Maintain06/11/2025
Roth/MKM
Buy5.00+120.26%6.00Maintain07/08/2025
B.Riley
Hold4.00+76.21%8.00Downgrade07/08/2025
Truist Securities
Buy6.00+164.32%7.00Maintain07/08/2025

Earnings

Latest Release
Nov 05, 2025
EPS / Forecast
0.22 / 0.13
Revenue / Forecast
48.00M / 52.53M
EPS Revisions
Last 90 days

People Also Watch

26.92
HFWA
+1.49%
27.83
CNOB
+1.09%
52.83
ACNB
+1.20%
30.10
ISTR
+2.31%

FAQ

What Is the biote Corp (BTMD) Share Price Today?

The live biote Corp share price today is 2.28

What Stock Exchange Does biote Corp (BTMD) Trade On?

biote Corp is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for biote Corp?

The stock symbol (also called a 'ticker') for biote Corp is "BTMD."

What Is the Current biote Corp Market Cap?

As of today, biote Corp market capitalisation is 97.72M.

What Is biote Corp's (BTMD) Earnings Per Share (TTM)?

The biote Corp EPS is currently 0.78 (Trailing Twelve Months).

When Is the Next biote Corp Earnings Date?

biote Corp's next earnings report will be released on 18 Mar 2026.

Is BTMD a Buy or Sell From a Technical Analyst Perspective?

Based on today's biote Corp moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has biote Corp Stock Split?

biote Corp has split 0 times. (See the BTMD stock split history page for full effective split date and price information.)

How Many Employees Does biote Corp Have?

biote Corp has 217 employees.

What is the current trading status of biote Corp (BTMD)?

As of 04 Feb 2026, biote Corp (BTMD) is trading at a price of 2.28, with a previous close of 2.14. The stock has fluctuated within a day range of 2.15 to 2.31, while its 52-week range spans from 2.03 to 5.15.

What Is biote Corp (BTMD) Price Target According to Analysts?

The average 12-month price target for biote Corp is USD4.21, with a high estimate of USD5.56 and a low estimate of USD3. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +84.74% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.